Low-dose CBD extract unexpectedly improved social behavior and anxiety in a 15-year-old with autism | Research

The takeaway

A 15-year-old with autism, selective mutism, anxiety, and controlled epilepsy showed unexpected improvements in social behavior and core autism symptoms at a lower CBD dose than previously reported for autism.

Autism clinicians, parents exploring CBD for autism, and researchers studying cannabinoids in neurodevelopmental disorders.

Core social deficits improved at lower CBD dose than expected

What the researchers found

A 15-year-old boy with autism, selective mutism, anxiety, and controlled epilepsy was prescribed CBD-based extract to potentially replace seizure medications. At a lower dose than typically reported for autism, he showed unanticipated improvements in behavioral symptoms, core social communication abilities, anxiety, sleep, and weight control. The social improvements were notable because they addressed core autism deficits, not just associated behaviors.

Why it matters

Current autism medications target associated symptoms (irritability, anxiety) but not the core social communication deficits. This case is notable because social improvements were observed at a dose lower than expected, suggesting a potential therapeutic window.

The numbers in context

One 15-year-old patient; dose lower than previously reported for ASD; improvements in social communication, anxiety, sleep, and weight.

How the study worked

Single case report documenting response to pharmaceutical-grade CBD-based extract in a 15-year-old with comorbid autism spectrum disorder, selective mutism, anxiety, and epilepsy.

What this study cannot tell us

Single case report (cannot generalize); multiple comorbidities confound attribution; placebo effects possible; no standardized outcome measures described; dose specifics not fully detailed in abstract; prior epilepsy medication changes could contribute.

How to read the evidence

Preliminary: single case report; intriguing but no generalizability.

When this study was published

Published 2020.

The bigger picture

The endocannabinoid system is increasingly implicated in social behavior. This case adds to a small but growing literature suggesting cannabinoids may address the core social deficits of autism, not just comorbid symptoms.

Questions still open

Is there an optimal low-dose CBD range for autism social symptoms? Does the epilepsy comorbidity affect response to CBD in autism?

Common questions

Can CBD help autism?

This single case reported improvements in core social communication and behavioral symptoms in a 15-year-old with autism taking CBD extract. However, this is only one patient and cannot establish whether CBD reliably helps autism symptoms.

What autism symptoms improved with CBD?

The patient showed improvements in core social communication abilities (the hallmark deficit of autism), behavioral symptoms, anxiety, sleep difficulties, and weight control, at a lower dose than previously reported.

Read the original research

A pediatric patient with autism spectrum disorder and epilepsy using cannabinoid extracts as complementary therapy: a case report.

Journal of medical case reports, 14(1), 162

View on PubMed ↗Publisher’s paper ↗

Citation

Ponton, Juliana Andrea; Smyth, Kim; Soumbasis, Elias; Llanos, Sergio Andres; Lewis, Mark; Meerholz, Wilhelm August; Tanguay, Robert Lawrence. (2020). A pediatric patient with autism spectrum disorder and epilepsy using cannabinoid extracts as complementary therapy: a case report.. Journal of medical case reports, 14(1), 162. https://doi.org/10.1186/s13256-020-02478-7